14-day Premium Trial Subscription Try For FreeTry Free
$4.74
-0.0900 (-1.86%)
At Close: May 01, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $4.40 $5.74 Wednesday, 1st May 2024 VTGN stock ended at $4.74. This is 1.86% less than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 4.24% from a day low at $4.72 to a day high of $4.92.
90 days $3.91 $5.74
52 weeks $1.62 $24.71

Historical VistaGen Therapeutics Inc prices

Date Open High Low Close Volume
Jun 09, 2022 $33.00 $33.60 $30.00 $30.90 35 813
Jun 08, 2022 $32.10 $34.20 $31.50 $33.00 30 770
Jun 07, 2022 $31.20 $32.10 $30.90 $32.10 34 190
Jun 06, 2022 $34.80 $34.80 $30.90 $31.80 41 230
Jun 03, 2022 $34.80 $36.00 $34.20 $34.50 43 233
Jun 02, 2022 $34.50 $35.70 $33.00 $35.10 18 627
Jun 01, 2022 $34.50 $36.60 $33.60 $34.20 33 440
May 31, 2022 $31.80 $35.10 $31.80 $34.50 40 603
May 27, 2022 $30.60 $34.20 $30.60 $31.80 64 217
May 26, 2022 $30.30 $30.90 $30.00 $30.60 20 203
May 25, 2022 $30.30 $31.80 $29.70 $30.60 30 940
May 24, 2022 $30.30 $31.50 $28.80 $30.60 33 613
May 23, 2022 $32.40 $32.40 $30.30 $31.20 30 227
May 20, 2022 $34.20 $34.50 $30.90 $31.50 45 297
May 19, 2022 $33.60 $35.40 $33.00 $33.30 23 300
May 18, 2022 $34.80 $36.30 $33.00 $34.20 29 147
May 17, 2022 $37.20 $37.50 $35.10 $36.00 23 033
May 16, 2022 $34.20 $36.30 $33.90 $35.70 20 027
May 13, 2022 $33.30 $35.40 $32.40 $34.20 25 437
May 12, 2022 $33.00 $33.60 $32.40 $33.00 24 343
May 11, 2022 $34.80 $36.30 $31.80 $32.70 28 277
May 10, 2022 $36.00 $36.30 $33.60 $35.40 53 637
May 09, 2022 $37.50 $39.30 $34.80 $35.40 37 373
May 06, 2022 $41.70 $42.30 $37.80 $38.10 31 013
May 05, 2022 $43.20 $43.80 $41.10 $42.30 59 357
Click to get the best stock tips daily for free!

About VistaGen Therapeutics Inc

VistaGen Therapeutics VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III development for the acute treatment of anxiety in adults with social anxiety disorder. Its PH94B product... VTGN Profile

Golden Star

Ticker Date Change Price
HRB Apr 29 1.00% $47.23
LYG Apr 29 0.391% $2.56
ORA Apr 29 1.95% $64.48
ETSY Apr 26 3.43% $67.43
DHT Apr 24 0.98% $11.28
LPLA Apr 19 1.10% $262.59
MLI Apr 19 7.29% $52.28
PFLT Apr 18 1.33% $11.25
DOOR Apr 18 0.94% $131.39
OCSL Apr 17 0.360% $19.43
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT